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Abstract: Body fat content and distribution might have an effect on ovarian reserves. Here, we studied the effects of 
body fat distribution on the antral follicle count (AFC) of women who consulted for infertility. In this two-center study, the 
ovarian reserves of patients who came to the hospital for infertility treatment was evaluated based on their AFC and 
early follicular phase follicle-stimulating hormone (FSH) levels. In addition, adiposity was evaluated using their body 
mass index (BMI) and waist-to-hip ratios (WHRs), the subcutaneous tissue thickness of the bicipital and tricipital regions, 
and the body adiposity index (BAI). Body fat distribution was evaluated using bioelectrical impedance analysis (BIA). We 
evaluated 58 patients in this study. While we failed to show a relationship between BMI and WHR based on the AFC, 
there was a significant relationship between body fat percentage and the AFC. The AFC in patients with < 35% body fat 
and  35% body fat was 11.54 ± 4.27 and 9.00 ± 3.95, respectively (p = 0.029). There was no significant relationship 
between the AFC and the WHR, BAI, and bicipital and tricipital subcutaneous tissue thickness. BMI may not reflect the 
adiposity of every patient. When evaluating the ovarian reserves of patients, we must consider other measures of obesity 
that reflect body fatness. Further large studies must be conducted to investigate the relationship between body fat and 
infertility.  
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INTRODUCTION 
Obesity is an increasingly serious health concern 
worldwide, and its association with many diseases has 
been demonstrated. Obesity as it relates to infertility is 
also being studied. The effects of obesity on ovarian 
reserves are being debated. While some studies reveal 
negative effects of obesity on ovarian reserves [1-4], 
others reveal conflicting results [5-6].  
All these studies used body mass index (BMI) to 
determine obesity. Although it is the most commonly 
used parameter to measure obesity, BMI does not 
provide an accurate measure of a person’s body 
composition, including body fat [7]. There seems to be 
an ‘obesity paradox’, as some studies have shown 
unexpected beneficial effects of obesity on 
cardiovascular diseases. Some researchers later 
showed that WHR and wrist circumference are better 
predictors of cardiovascular events [8-9]. It was 
concluded that while some obese people are 
metabolically healthy, other normal weight people 
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might be metabolically obese [10]. This might be either 
because of the body fat content or the body fat 
distribution of individuals.  
Adipose tissue can be categorized as truncal adi- 
pose tissue, which includes visceral and subcutaneous 
fat in the thorax and abdomen, and peripheral adipose 
tissue, which includes subcutaneous fat in the extremi- 
ties. In a study of menopausal women, it was demons- 
trated that central adiposity is a stronger cardiac risk 
factor compared to peripheral adiposity [11]. 
These conflicting findings result in our hypothesis 
that the content and distribution of body fat might affect 
ovarian reserves more than BMI.  
Bioelectrical impedance analysis (BIA) is 
noninvasive, easy, and radiation-free compared to the 
dual energy X-ray absorptiometry (DEXA) technique 
used to measure fat distribution in the body. BIA has 
been demonstrated to be an effective method to 
estimate total abdominal fat [12]. Previously, it was 
demonstrated that BIA can be used to accurately 
estimate body fat distribution, and the results correlate 
well with DEXA results, except for very obese women 
(BMI > 35) [13-14]. 
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In this study, we investigated the possible 
relationship between ovarian reserves and BMI, WHR, 
subcutaneous tissue thicknesses measured using 
calipers, and body fat distribution.  
MATERIALS AND METHODS 
This two-center study was conducted at Canakkale 
Onsekiz Mart University (COMU) Hospital and Gulhane 
Askeri Tip Akademisi (GATA) Hospital between 1 April 
2013 and 31 October 2013. Local ethics committee 
approval and the written consent of the participants 
were obtained. 
Patients with a history of surgery that might affect 
ovarian reserves and those with ovarian cysts, 
endometrioma, polycystic ovarian syndrome [15], or 
chronic illness were excluded, as were patients over 
40. After obtaining the consent of patients, their socio-
demographic information and medical histories were 
recorded. A gynecologist examined the patients when 
they were in the early follicular phase of their menstrual 
cycle using transvaginal ultrasonography. Their AFC 
was noted.  
The anthropometric measurements of all patients 
were taken when they were in the early follicular phase 
of menstruation. The measurements were taken in the 
morning when the patients were in a fasting state, 
according to the International Standards for Anthropo- 
metric Assessment [16]. Measurements were taken by 
a dietitian at GATA Hospital and by a well-trained nurse 
at COMU Hospital. The patients’ height, weight, waist 
and hip circumferences, and foot-to-foot BIA were mea- 
sured. Next, their BMIs and WHRs were calculated, 
and their subcutaneous fat thickness in the bicipital and 
tricipital regions was measured using a skinfold caliper.  
Weight to the nearest 0.1 kg was determined using 
a Tanita multi-frequency body composition analyzer 
(MC-418MA; Tanita Corporation, Tokyo, Japan). Height 
to the nearest 0.5 cm was determined using a 
stadiometer. 
BMI was calculated as weight in kilograms divided 
by height in square meters. According to the World 
Health Organization (WHO), overweightness is defined 




Waist circumference was measured at the level of 
the umbilicus while patients were standing, and hip 
circumference was measured at the broadest part of 
the hip. 
WHR was calculated by dividing waist 
circumference by hip circumference. A WHR  0.85 
was accepted as normal and a WHR > 0.85 was 
accepted as high.  




BIA was performed using the Tanita multi-frequency 
body composition analyzer (MC-418MA; Tanita Corpo- 
ration, Tokyo, Japan). The age, sex, and height of the 
patients were recorded to the analyzer before mea- 
surement. The patients stood on the scale barefooted, 
holding the analyzer handgrips. Impedance against a 
small electrical current sent through the body was 
measured according to the conductive properties of the 
tissue. Fat mass (FM) has a higher impedance and fat-
free mass (FFM) has a lower impedance. The basal 
metabolic rate, body fat percentage, truncal fat percent- 
age, and fat percentage of the extremities of each 
patient were automatically calculated by the analyzer.  
Statistical analysis was performed using version 
15.0 of the Statistical Package for Social Sciences 
version (SPSS Inc., Chicago, IL). All continuous 
variables were expressed as mean ± standard 
deviation (SD). All measurements were evaluated 
using the Kolmogorov–Smirnov test and the Shapiro-
Wilk test to determine normal distribution. A p-value < 
0.05 was accepted as significant. 
RESULTS 
Of the 58 patients included in the study, 15 
participated at COMU Hospital and 43 participated at 
GATA Hospital. The mean age was 32.39 ± 8.76, the 
duration of infertility was 4.31 ± 2.71 years, the mean 
follicle-stimulating hormone (FSH) level was 6.59 ± 
2.45, the mean luteinizing hormone (LH) level was 5.81 
± 2.26, the mean AFC was 10.21 ± 4.20, and the mean 
BMI was 25.61± 5.81.  
The patients were grouped according to BMI. There 
were 32 patients in the normal weight group, 14 
patients in the overweight group, and 12 patients in the 
obese group. The AFC and FSH levels of the groups 
were compared and no significant differences were 
found (Table 1).  
Next, the patients were grouped according to WHR. 
There were 38 patients in the normal WHR group and 
18 in the high WHR group. There was no significant 
difference between the groups for either AFC or FSH 
levels (Table 2). 
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Table 1: Comparison of Patients According to BMI 







Age 29.69±4.41 30.37±4.01 29.92±4.78 0.873 
Duration of 
infertility 
4.08±2.96 5.80±2.68 3.29±1.50 0.042 
AFC 11.57±4.05 11.43±5.29 8.83±3.49 0.157 
FSH 6.94±2.76 6.45±1.75 5.94±2.02 0.464 
LH 5.75±1.98 6.27±3.03 5.30±2.04 0.584 
E2 46.67±19.21 50.42±28.38 32.43±13.38 0.161 
 
Table 2: Comparison of AFC According to WHR 
 WHR0.85 (n: 42) WHR>0.85 (n: 19) P 
Age 29.38±4.09 30.63±4.81 0.300 
Duration of 
infertility 
4.81±3.07 3.53±1.76 0.104 
AFC 11.45±4.30 10.05±4.42 0.247 
FSH 6.66±1.89 6.71±3.33 0.941 
LH 6.11±2.44 5.30±1.96 0.235 
E2 46.47±21.95 38.18±18.35 0.161 
 
The patients were then re-grouped according to 
body fat. There were 37 patients in the normal body fat 
group and 21 in the high body fat group. The groups 
were similar in terms of age, infertility duration, and 
FSH and LH levels; however, the AFC was significantly 
higher in the normal body fat group compared to the 
high body fat group (Table 3). 
Table 3: Comparison of AFC According to Body Fat 
 Body Fat<35 (n:42) Body Fat35 (n:21) P 
Age 29.62±4.44 30.48±4.13 0.463 
Duration of 
infertility 
4.21±2.87 4.62±2.59 0.591 
AFC 12.02±4.27 9.00±3.95 0.008 
FSH 6.76±2.67 6.38±1.79 0.563 
LH 5.89±2.43 5.63±2.03 0.696 
E2 46.34±17.67 43.10±29.58 0.633 
 
Next, the patients were further divided into two 
groups according to AFC. There were 30 patients in the 
group with an AFC  10 and 28 in the group with an 
AFC  11. When the basal metabolic rates, truncal fat 
percentage, mean upper extremity and lower extremity 
fat percentages, BAI, and bicipital and tricipital 
subcutaneous tissue thickness of these groups were 
measured, we found no significant differences.  
DISCUSSION AND CONCLUSION 
While we failed to show a relationship between BMI 
and AFC, we found that patients with a lower body fat 
percentage had a significantly higher AFC. AFC is a 
good ovarian reserve marker to predict the number of 
retrieved and mature oocytes, which directly affects in 
vitro fertilization (IVF) outcomes [19]. Thus, we used 
AFC as the predictor of ovarian reserves. The results of 
studies about obesity and either ovarian reserves or 
IVF success are conflicting. 
Haghighi et al. [20] found no relationship between 
BMI and the number of retrieved oocytes in the first IVF 
cycle of 230 women. Malhotra et al. [1] demonstrated 
that obesity has no effect on AFC but significantly 
decreases inhibin B levels. Sahmay et al. [2] evaluated 
222 premenopausal women and concluded there is no 
relationship between obesity and ovarian reserves. In a 
retrospective study conducted in 2010, obesity had no 
significant adverse effect on early follicular phase FSH 
levels [3]. Halawaty et al. [4] evaluated the ovarian 
reserves of 50 non-obese and 50 obese 
premenopausal patients. There was no significant 
difference between the groups when they compared 
ovarian reserves. Su et al. [6] found significantly 
decreased anti mullerian hormone (AMH) levels but no 
relationship between AFC and obesity in the late 
reproductive period of patients. In a retrospective study 
of female childhood cancer survivors, it was found that 
obesity causes lower AMH; however, the patients’ AFC 
was not related to obesity [21]. Spandorfer et al. [22] 
showed that although obese IVF patients have an 
increased cycle cancellation rate, there are similar 
pregnancy rates for non-obese IVF patients. Kilic et al. 
[23] also found no relationship between BMI and 
ovarian response to IVF treatment. Martinuzzi et al. 
[24] also found no relationship between obesity and 
IVF outcomes in their retrospective study. In a large 
study of an IVF population, no significant relationship 
was found between BMI and AFC [25]. 
Fecundity has been found to be reduced among 
obese and overweight women [26-28]. In a recent 
meta-analysis, it was shown that obese and overweight 
women had worse IVF outcomes compared to normal 
weight patients [29]. In terms of infertility risk, 
Esmaeilzadeh et al. (30) found a 4.8-fold increment for 
obese women and a 3.8-fold increment for overweight 
women. Freeman et al. [5] evaluated 122 women in 
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their late reproductive period and found that women 
with a BMI  30 have significantly lower AMH levels 
compared to patients with a BMI < 30. Hollman et al. 
[31] found that women with a WHR  0.85 experience 
more infertility. Zaidi et al. [32] showed that increased 
BMI results in decreased ovarian volume. Ben-Haroush 
et al. [33] found a weak relationship between BMI and 
AFC. Recently, in a large population-based study of 
black women, it was found that both increased BMI and 
central obesity cause reduced fertility and increase the 
time it takes to get pregnant [34]. Wass et al. [35] 
evaluated 220 women who underwent in vitro 
fertilization embryo transfer (IVF-ET) and grouped 
patients according to WHR. They concluded that 
patients with android-type fat distribution had lower 
pregnancy rates. Buyuk et al. [36] found that obese and 
overweight patients with diminished ovarian reserves 
have lower serum AMH levels and fewer retrieved 
oocytes compared to normal weight patients with 
diminished ovarian reserve Luke et al. [37] conducted a 
study of 152,500 artificial reproductive treatment cycles 
and concluded that increased BMI increases cycle 
cancellation rates and pregnancy failure rates. 
As concluded in cardiology studies, having a high 
BMI does not always mean having more adipose 
tissue. Logically, obesity must affect ovarian reserves 
due to the metabolic effects of adipocytes. We need to 
determine the amount of metabolically active adipose 
tissue rather than the whole body mass of patients 
when evaluating ovarian reserves.  
Our findings are compatible with the literature, 
which did not find any adverse effects of BMI on AFC. 
The main limitation of our study is the relatively small 
sample size, which is due to the strict exclusion criteria. 
A vast majority of infertile patients who had either 
polycystic ovaries or endometrioma were excluded 
from our study. Patients who underwent ovarian 
surgeries or who were over 40 years old were also 
excluded.  
In conclusion, adiposity rather than obesity has 
some direct adverse effects on ovarian reserves and 
might have indirect adverse effects on fertility. To our 
knowledge, this is the first study that has investigated 
the effect of body fat on ovarian reserves. The possible 
effects of body fat and its distribution on infertility and 
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